Nina Shand couldn’t stay awake. She had taken afternoon naps since she was a teenager to accommodate her “work hard, play hard” attitude, but when she was in her mid-20s the sleepiness became more ...

The burden of living with narcolepsy is high, and it starts at a young age, according to Luis Ortiz, M.D., assistant ...

Posters presented at the SLEEP 2023 conference showed that transition between medications was easy but 1 medication felt more effective to patients. Switching from high-sodium oxybate (SXB) to ...

Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of ...

Narcolepsy management should be a combination of behavioral and pharmacologic strategies that are tailored to the patient with consideration of the impact of symptoms and how they may evolve, ...

Oveporexton significantly improves wakefulness and reduces cataplexy frequency in patients with narcolepsy type 1, according ...

In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment. Narcolepsy ...

NASHVILLE, Tenn. -- People with narcolepsy frequently had mood and pain comorbidities that complicated diagnosis and treatment plans, observational data showed. "A lot of times when someone has ...

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed by ...

INDIANAPOLIS -- Extended-release sodium oxybate (Lumryz) taken once before bedtime was preferred by patients with narcolepsy over twice-nightly dosing and was generally well tolerated, according to ...